Literature DB >> 19070412

Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.

Daniel E Weiner1, Keith Bartolomei, Tammy Scott, Lori Lyn Price, John L Griffith, Irwin Rosenberg, Andrew S Levey, Marshal F Folstein, Mark J Sarnak.   

Abstract

BACKGROUND: Albuminuria, a kidney marker of microvascular disease, may herald microvascular disease elsewhere, including in the brain. STUDY
DESIGN: Cross sectional. SETTING & PARTICIPANTS: Boston, MA, elders receiving home health services to maintain independent living who consented to brain magnetic resonance imaging. PREDICTOR: Urine albumin-creatinine ratio (ACR). OUTCOME: Performance on a cognitive battery assessing executive function and memory by using principal components analysis and white matter hyperintensity volume on brain imaging, evaluated in logistic and linear regression models.
RESULTS: In 335 participants, mean age was 73.4 +/- 8.1 years and 123 participants had microalbuminuria or macroalbuminuria. Each doubling of ACR was associated with worse executive function (beta = -0.05; P = 0.005 in univariate and beta = -0.07; P = 0.004 in multivariable analyses controlling for age, sex, race, education, diabetes, cardiovascular disease, hypertension, medications, and estimated glomerular filtration rate [eGFR]), but not with worse memory or working memory. Individuals with microalbuminuria or macroalbuminuria were more likely to be in the lower versus the highest tertile of executive functioning (odds ratio, 1.18; 95% confidence interval, 1.06 to 1.32; odds ratio, 1.19; 95% confidence interval, 1.05 to 1.35 per doubling of ACR in univariate and multivariable analyses, respectively). Albuminuria was associated with qualitative white matter hyperintensity grade (odds ratio, 1.13; 95% confidence interval, 1.02 to 1.25; odds ratio, 1.15; 95% confidence interval, 1.02 to 1.29 per doubling of ACR) in univariate and multivariable analyses and with quantitative white matter hyperintensity volume (beta = 0.11; P = 0.007; beta = 0.10; P = 0.01) in univariate and multivariable analyses of log-transformed data. Results were similar when excluding individuals with macroalbuminuria. LIMITATIONS: Single measurement of ACR, indirect creatinine calibration, and reliance on participant recall for elements of medical history.
CONCLUSIONS: Albuminuria is associated with worse cognitive performance, particularly in executive functioning, as well as increased white matter hyperintensity volume. Albuminuria likely identifies greater brain microvascular disease burden.

Entities:  

Mesh:

Year:  2008        PMID: 19070412      PMCID: PMC2786493          DOI: 10.1053/j.ajkd.2008.08.022

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  31 in total

1.  Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.

Authors:  Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick de Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick E Grobbee; Paul E de Jong
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

Review 2.  Subcortical ischaemic vascular dementia.

Authors:  Gustavo C Román; Timo Erkinjuntti; Anders Wallin; Leonardo Pantoni; Helena C Chui
Journal:  Lancet Neurol       Date:  2002-11       Impact factor: 44.182

3.  Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.

Authors:  Oscar L Lopez; William J Jagust; Corinne Dulberg; James T Becker; Steven T DeKosky; Annette Fitzpatrick; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller
Journal:  Arch Neurol       Date:  2003-10

Review 4.  Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Manjula Kurella Tamura; Virginia Wadley; Kristine Yaffe; Leslie A McClure; George Howard; Rodney Go; Richard M Allman; David G Warnock; William McClellan
Journal:  Am J Kidney Dis       Date:  2008-06-30       Impact factor: 8.860

5.  Albuminuria and dementia in the elderly: a community study.

Authors:  Joshua I Barzilay; Annette L Fitzpatrick; Jose Luchsinger; Sevil Yasar; Charles Bernick; Nancy S Jenny; Lewis H Kuller
Journal:  Am J Kidney Dis       Date:  2008-05-12       Impact factor: 8.860

6.  Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study.

Authors:  M F Yuyun; K-T Khaw; R Luben; A Welch; S Bingham; N E Day; N J Wareham
Journal:  J Intern Med       Date:  2004-02       Impact factor: 8.989

7.  Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway.

Authors:  Solfrid Romundstad; Jostein Holmen; Kurt Kvenild; Hans Hallan; Hanne Ellekjaer
Journal:  Am J Kidney Dis       Date:  2003-09       Impact factor: 8.860

Review 8.  Vascular dementia: distinguishing characteristics, treatment, and prevention.

Authors:  Gustavo C Román
Journal:  J Am Geriatr Soc       Date:  2003-05       Impact factor: 5.562

9.  Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.

Authors:  Kristian Wachtell; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Peter M Okin; Per Omvik; Suzanne Oparil; Hans Wedel; Steven M Snapinn; Peter Aurup
Journal:  Ann Intern Med       Date:  2003-12-02       Impact factor: 25.391

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  78 in total

1.  Depression and cognitive function in maintenance hemodialysis patients.

Authors:  Brian T Agganis; Daniel E Weiner; Lena M Giang; Tammy Scott; Hocine Tighiouart; John L Griffith; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2010-07-29       Impact factor: 8.860

Review 2.  Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies.

Authors:  Manjula Kurella Tamura; Kristine Yaffe
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

3.  Albuminuria and cognitive decline in people with diabetes and normal renal function.

Authors:  Joshua I Barzilay; James F Lovato; Anne M Murray; Jeff Williamson; Faramaz Ismail-Beigi; Diane Karl; Vasilios Papademetriou; Lenore J Launer
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

4.  Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND.

Authors:  Mariana Murea; Fang-Chi Hsu; Amanda J Cox; Christina E Hugenschmidt; Jianzhao Xu; Jeremy N Adams; Laura M Raffield; Christopher T Whitlow; Joseph A Maldjian; Donald W Bowden; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2015-02-26       Impact factor: 5.992

Review 5.  Aging and chronic kidney disease: the impact on physical function and cognition.

Authors:  Shuchi Anand; Kirsten L Johansen; Manjula Kurella Tamura
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-02       Impact factor: 6.053

6.  Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States.

Authors:  Manjula Kurella Tamura; Paul Muntner; Virginia Wadley; Mary Cushman; Neil A Zakai; Brian D Bradbury; Brett Kissela; Fred Unverzagt; George Howard; David Warnock; William McClellan
Journal:  Am J Kidney Dis       Date:  2011-08-04       Impact factor: 8.860

Review 7.  Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.

Authors:  David A Drew; Daniel E Weiner; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

8.  Chronic kidney disease, creatinine and cognitive functioning.

Authors:  Merrill F Elias; Penelope K Elias; Stephen L Seliger; Sriram S Narsipur; Gregrory A Dore; Michael A Robbins
Journal:  Nephrol Dial Transplant       Date:  2009-03-18       Impact factor: 5.992

Review 9.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

10.  Reference data for the Ruff Figural Fluency Test stratified by age and educational level.

Authors:  Gerbrand J Izaks; Hanneke Joosten; Janneke Koerts; Ron T Gansevoort; Joris P Slaets
Journal:  PLoS One       Date:  2011-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.